Indivumed Services, a subsidiary of Crown Bioscience, offers comprehensive biobank products, laboratory services, and research partnerships, specializing in biospecimen immuno-oncology biomarker discovery and validation, as well as drug profiling.
Indivumed Therapeutics, on the other hand, focuses on AI-assisted advanced analytics for novel discoveries in multi-omics-based oncology R&D, providing services such as target identification and validation, patient-based cellular models, and optimized clinical study design tailored to specific targets.
Generated from the website